132 related articles for article (PubMed ID: 27920420)
1. Treatment Effectiveness of Amantadine Against Dengue Virus Infection.
Lin CC; Chen WC
Am J Case Rep; 2016 Dec; 17():921-924. PubMed ID: 27920420
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of amantadine hydrochloride in patients with epidemic influenza A virus infection].
Ito S; Iijima N; Kanemaki K; Hayashi S; Hujii S; Watanabe T; Hosokawa T; Kakehi K
Nihon Kokyuki Gakkai Zasshi; 2000 Dec; 38(12):897-902. PubMed ID: 11244724
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
4. A Multi-centric, Double-blind, Placebo-controlled, Randomized, Prospective Study to Evaluate the Efficacy and Safety of Carica papaya Leaf Extract, as Empirical Therapy for Thrombocytopenia associated with Dengue Fever.
Kasture PN; Nagabhushan KH; Kumar A
J Assoc Physicians India; 2016 Jun; 64(6):15-20. PubMed ID: 27739262
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
Nguyen JT; Smee DF; Barnard DL; Julander JG; Gross M; de Jong MD; Went GT
PLoS One; 2012; 7(1):e31006. PubMed ID: 22292088
[TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
Younossi ZM; McCullough AC; Barnes DS; Post A; Ong JP; O'Shea R; Martin LM; Bringman D; Farmer D; Levinthal G; Mullen KD; Carey WD; Tavill AS; Ferguson R; Gramlich T
Dig Dis Sci; 2005 May; 50(5):970-5. PubMed ID: 15906777
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.
Low JG; Sung C; Wijaya L; Wei Y; Rathore APS; Watanabe S; Tan BH; Toh L; Chua LT; Hou Y; Chow A; Howe S; Chan WK; Tan KH; Chung JS; Cherng BP; Lye DC; Tambayah PA; Ng LC; Connolly J; Hibberd ML; Leo YS; Cheung YB; Ooi EE; Vasudevan SG
Lancet Infect Dis; 2014 Aug; 14(8):706-715. PubMed ID: 24877997
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of newer treatment strategies for influenza.
Smith KJ; Roberts MS
Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory predictive markers for acute dengue infection.
Ho TS; Wang SM; Lin YS; Liu CC
J Biomed Sci; 2013 Oct; 20(1):75. PubMed ID: 24138072
[TBL] [Abstract][Full Text] [Related]
10. Innate Antiviral Immunity against Dengue Virus.
Makhluf H; Shresta S
Crit Rev Immunol; 2015; 35(3):253-60. PubMed ID: 26559229
[TBL] [Abstract][Full Text] [Related]
11. Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.
Zilly M; Lingenauber C; Desch S; Väth T; Klinker H; Langmann P
Eur J Med Res; 2002 Apr; 7(4):149-54. PubMed ID: 12010649
[TBL] [Abstract][Full Text] [Related]
12. Antiviral actions of flavanoid-derived compounds on dengue virus type-2.
Muhamad M; Kee LY; Rahman NA; Yusof R
Int J Biol Sci; 2010 May; 6(3):294-302. PubMed ID: 20567498
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a dengue hemorrhagic fever outbreak in 2001 in Kaohsiung.
Lai PC; Lee SS; Kao CH; Chen YS; Huang CK; Lin WR; Wann SR; Lin HH; Yen MY; Liu YC
J Microbiol Immunol Infect; 2004 Oct; 37(5):266-70. PubMed ID: 15497006
[TBL] [Abstract][Full Text] [Related]
14. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD
Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia.
Khan NA; Azhar EI; El-Fiky S; Madani HH; Abuljadial MA; Ashshi AM; Turkistani AM; Hamouh EA
Acta Trop; 2008 Jan; 105(1):39-44. PubMed ID: 17983609
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of early dipyrone administration on severity of dengue virus infection in a prospective cohort].
Díaz-Quijano FA; Villar-Centeno LA; Martínez-Vega RA
Enferm Infecc Microbiol Clin; 2005 Dec; 23(10):593-7. PubMed ID: 16324548
[TBL] [Abstract][Full Text] [Related]
17. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
Kim WY; Young Suh G; Huh JW; Kim SH; Kim MJ; Kim YS; Kim HR; Ryu YJ; Han MS; Ko YG; Chon GR; Lee KH; Choi SH; Hong SB;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5703-9. PubMed ID: 21968371
[TBL] [Abstract][Full Text] [Related]
18. Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.
Sung C; Wei Y; Watanabe S; Lee HS; Khoo YM; Fan L; Rathore AP; Chan KW; Choy MM; Kamaraj US; Sessions OM; Aw P; de Sessions PF; Lee B; Connolly JE; Hibberd ML; Vijaykrishna D; Wijaya L; Ooi EE; Low JG; Vasudevan SG
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004851. PubMed ID: 27509020
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of amantadine in elderly patients with chronic hepatitis C.
Torre F; Campo N; Giusto R; Ansaldi F; Icardi GC; Picciotto A
Gerontology; 2001; 47(6):330-3. PubMed ID: 11721147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
